Relationship between Medication-Related Osteonecrosis of the Jaw and CDK4/6 Inhibitors in Breast Cancer

Relationship between Medication-Related Osteonecrosis of the Jaw and CDK4/6 Inhibitors in Breast Cancer

Objective: We aimed to evaluate the use of CDK4/6 inhibitors as a risk factor for medication-related osteonecrosis of the jaw (MRONJ) in a cohort of patients with metastatic breast cancer treated with denosumab. Methods: This was a multicentre, retrospective, observational study. All patients with b...

Full description

Bibliographic Details
Main Authors: Loreto Domínguez Senín, David Morales Pancorbo, María Yeray Rodríguez Garcés, María Dolores Santos-Rubio, Juan Bayo Calero
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Current Oncology
Subjects:
MRONJ
CDK4/6 inhibitors
metastatic breast cancer
oral epidemiology
Online Access:https://www.mdpi.com/1718-7729/31/1/16

Similar Items

Similar Items